F269-0416 Screening compound: N-[1-(4,5-dimethyl-6-oxo-1,6-dihydropyrimidin-2-yl)-3-methyl-1H-pyrazol-5-yl]-3,5-bis(trifluoromethyl)benzamide

F269-0416 Screening compound: N-[1-(4,5-dimethyl-6-oxo-1,6-dihydropyrimidin-2-yl)-3-methyl-1H-pyrazol-5-yl]-3,5-bis(trifluoromethyl)benzamide
F269-0416 Screening compound: N-[1-(4,5-dimethyl-6-oxo-1,6-dihydropyrimidin-2-yl)-3-methyl-1H-pyrazol-5-yl]-3,5-bis(trifluoromethyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F269-0416
N-[1-(4,5-dimethyl-6-oxo-1,6-dihydropyrimidin-2-yl)-3-methyl-1H-pyrazol-5-yl]-3,5-bis(trifluoromethyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F269-0416

Molecular Formula

C19H15F6N5O2 (C19 H15 F6 N5 O2)

Compound Name

N-[1-(4,5-dimethyl-6-oxo-1,6-dihydropyrimidin-2-yl)-3-methyl-1H-pyrazol-5-yl]-3,5-bis(trifluoromethyl)benzamide

IUPAC name

N-[1-(45-dimethyl-6-oxo-16-dihydropyrimidin-2-yl)-3-methyl-1H-pyrazol-5-yl]-35-bis(trifluoromethyl)benzamide

SMILES

Cc(cc1NC(c2cc(C(F)(F)F)cc(C(F)(F)F)c2)=O)nn1C(N1)=NC(C)=C(C)C1=O

InChI

InChI=1S/C19H15F6N5O2/c1-8-4-14(30(29-8)17-26-10(3)9(2)15(31)28-17)27-16(32)11-5-12(18(20,21)22)7-13(6-11)19(23,24)25/h4-7H,1-3H3,(H,27,32)(H,26,28,31)

InChI Key

PEPXUPNVFREQAZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD08536867

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

459.35

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.292

Distribution Coefficient, logD

2.147

Water Solubility, LogSw

-3.50

Polar Surface Area

71.489

Acid Dissociation Constant (pKa)

6.29

Base Dissociation Constant (pKb)

-2.71

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.30

F269-0416 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Arginase Targeted Library (2009 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

RNA-Protein Interaction Inhibitors Library (1986 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Male
  • Cardiovascular
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Others
  • Kinases

References: we are preparing a list of scientific research reports with F269-0416 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F269-0416?
Check Price and Availability of F269-0416, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F269-0416 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F269-0416
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F269-0416
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F269-0416 available by request